Stem cell shots aim to heal scleroderma finger sores
NCT ID NCT04356755
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether injecting a patient's own cultured fat stem cells into stubborn finger ulcers can help them heal. The study includes 32 adults with scleroderma who have at least one ulcer that hasn't healed with standard care. Half get stem cell injections, half get a placebo, and they are followed for 16 weeks to see if the ulcers shrink or close completely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cultured adipose-derived stem cells (AdMSC)
What this could lead to
If it works, this could offer a new way to heal painful finger ulcers in scleroderma patients who have no other options.
What could go wrong
This is a small, early-phase trial with only 32 people. The treatment may not work better than placebo, and there are risks like infection or worsening ulcers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Toulouse - Hôpital PURPAN-TSA
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grenoble Hospital
NOT_YET_RECRUITINGGrenoble, France
Contact
-
Lille Hopsital
NOT_YET_RECRUITINGLille, France
Contact
-
Marseille Hospital
NOT_YET_RECRUITINGMarseille, France
Contact
-
Montpellier Hospital
NOT_YET_RECRUITINGMontpellier, France
Contact
-
Nantes Hospital
NOT_YET_RECRUITINGNantes, France
Contact
-
Poitiers Hospital
NOT_YET_RECRUITINGPoitiers, France
Contact